Sandoz Strikes Shionogi Partnership as Part of Pain Play
• By Aidan Fry
By licensing European rights to Shionogi's Rizmoic opioid-induced constipation treatment, Sandoz is seeking to strengthen its pain portfolio • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
